The WACC of Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) is 8.7%.
| Range | Selected | |
| Cost of equity | 7.40% - 10.10% | 8.75% |
| Tax rate | 13.30% - 13.60% | 13.45% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.4% - 10.0% | 8.7% |
| Category | Low | High |
| Long-term bond rate | 2.1% | 2.6% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.91 | 1.02 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.40% | 10.10% |
| Tax rate | 13.30% | 13.60% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.4% | 10.0% |
| Selected WACC | 8.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 1858.HK:
cost_of_equity (8.75%) = risk_free_rate (2.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.91) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.